| Primary |
| Product Used For Unknown Indication |
22.1% |
| Parathyroidectomy |
14.0% |
| Parathyroid Disorder |
12.8% |
| Diagnostic Procedure |
11.6% |
| Scan Parathyroid |
10.5% |
| Surgery |
5.8% |
| Depression |
3.5% |
| Parathyroid Gland Operation |
3.5% |
| Vasoplegia Syndrome |
3.5% |
| Anxiety |
1.2% |
| Cataract Operation |
1.2% |
| Cecal Polyp |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Laboratory Test |
1.2% |
| Local Anaesthesia |
1.2% |
| Lung Disorder |
1.2% |
| Lymph Node Disorder |
1.2% |
| Obsessive-compulsive Disorder |
1.2% |
| Parathyroid Tumour |
1.2% |
| Scan |
1.2% |
|
| Off Label Use |
16.1% |
| Vomiting |
16.1% |
| Serotonin Syndrome |
12.9% |
| Post Procedural Complication |
9.7% |
| Toxicity To Various Agents |
6.5% |
| Unresponsive To Stimuli |
4.8% |
| Vision Blurred |
4.8% |
| Laboratory Test Interference |
3.2% |
| Pulseless Electrical Activity |
3.2% |
| Skin Lesion |
3.2% |
| Vertigo |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Anaphylactic Shock |
1.6% |
| Encephalopathy |
1.6% |
| Hypoxia |
1.6% |
| Immediate Post-injection Reaction |
1.6% |
| Infusion Site Haemorrhage |
1.6% |
| Injection Site Pain |
1.6% |
| Injection Site Reaction |
1.6% |
| Lymphorrhoea |
1.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.7% |
| Parathyroidectomy |
11.5% |
| Depression |
11.0% |
| Sedation |
8.2% |
| Analgesia |
5.9% |
| Preoperative Care |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Anaesthesia |
4.8% |
| Analgesic Therapy |
2.8% |
| Induction Of Anaesthesia |
2.3% |
| Scan Parathyroid |
2.3% |
| Lymphoma |
2.0% |
| General Anaesthesia |
1.7% |
| Drug Exposure In Utero |
1.4% |
| Maintenance Of Anaesthesia |
1.4% |
| Parathyroid Disorder |
1.4% |
| Antiemetic Supportive Care |
1.1% |
| General Anesthesia |
1.1% |
| Antidepressant Therapy |
0.8% |
| Encephalopathy |
0.8% |
|
| Serotonin Syndrome |
34.1% |
| White Blood Cell Count Increased |
14.8% |
| Vomiting |
9.1% |
| Staring |
6.8% |
| Drug Interaction |
5.7% |
| Toxic Encephalopathy |
4.5% |
| Tremor |
4.5% |
| Inhibitory Drug Interaction |
3.4% |
| Premature Baby |
2.3% |
| Unresponsive To Stimuli |
2.3% |
| Vision Blurred |
2.3% |
| Bone Marrow Failure |
1.1% |
| Exposure During Pregnancy |
1.1% |
| Mental Disorder |
1.1% |
| Mydriasis |
1.1% |
| Nystagmus |
1.1% |
| Parathyroid Tumour Benign |
1.1% |
| Premature Delivery |
1.1% |
| Pyrexia |
1.1% |
| Skin Discolouration |
1.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.0% |
| Prophylaxis |
8.8% |
| Urinary Tract Infection |
8.8% |
| Peritoneal Dialysis |
6.8% |
| Chemotherapy |
5.4% |
| Lymphoma |
4.8% |
| Diffuse Large B-cell Lymphoma |
3.4% |
| Parathyroidectomy |
3.4% |
| Premedication |
3.4% |
| Neoplasm Malignant |
2.7% |
| Pain |
2.7% |
| Antibiotic Level |
2.0% |
| Antiemetic Supportive Care |
2.0% |
| Constipation |
2.0% |
| Coronary Artery Bypass |
2.0% |
| Maintenance Of Anaesthesia |
2.0% |
| Anaesthesia Reversal |
1.4% |
| Anxiety |
1.4% |
| B-cell Lymphoma |
1.4% |
| Blood Pressure Systolic Decreased |
1.4% |
|
| Vomiting |
14.7% |
| Sclerosing Encapsulating Peritonitis |
11.8% |
| Serotonin Syndrome |
8.8% |
| Blood Creatinine Increased |
5.9% |
| Hyponatraemia |
5.9% |
| Methaemoglobinaemia |
5.9% |
| Myositis |
5.9% |
| Visual Impairment |
5.9% |
| Abdominal Pain |
2.9% |
| Anhedonia |
2.9% |
| Device Related Infection |
2.9% |
| Electrocardiogram St-t Segment Elevation |
2.9% |
| Encephalopathy |
2.9% |
| Febrile Neutropenia |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Hypotension |
2.9% |
| Multi-organ Failure |
2.9% |
| Nausea |
2.9% |
| Pain |
2.9% |
| Post Procedural Complication |
2.9% |
|
| Interacting |
| Chemotherapy |
12.9% |
| Parathyroidectomy |
12.9% |
| Product Used For Unknown Indication |
12.9% |
| Analgesic Therapy |
8.1% |
| Surgery |
8.1% |
| Antiemetic Supportive Care |
4.8% |
| Depression |
4.8% |
| Depressive Symptom |
4.8% |
| Nausea |
4.8% |
| Diagnostic Procedure |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Encephalopathy |
3.2% |
| Parathyroid Gland Operation |
3.2% |
| Vomiting |
3.2% |
| Agitation |
1.6% |
| Antidepressant Therapy |
1.6% |
| Breast Cancer |
1.6% |
| Confusional State |
1.6% |
| Imaging Procedure |
1.6% |
| Parathyroid Tumour |
1.6% |
|
| Serotonin Syndrome |
56.3% |
| Nystagmus |
12.5% |
| Unresponsive To Stimuli |
12.5% |
| Agitation |
6.3% |
| Dyskinesia |
6.3% |
| Tachycardia |
6.3% |
|
